41.17
price up icon6.88%   2.65
after-market Dopo l'orario di chiusura: 41.39 0.22 +0.53%
loading

Novo Nordisk Adr Borsa (NVO) Ultime notizie

pulisher
01:05 AM

Is This Tech Giant the Next Potential Winner in the GLP-1 Weight Loss Boom? - The Motley Fool

01:05 AM
pulisher
Apr 22, 2026

NVO Stock Price, Quote & Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill

Apr 22, 2026
pulisher
Apr 21, 2026

Novo Nordisk A/S stock (DK0062498333): Is its obesity drug dominance strong enough to sustain long-t - AD HOC NEWS

Apr 21, 2026
pulisher
Apr 20, 2026

[6-K] NOVO NORDISK A S Current Report (Foreign Issuer) | NVO SEC FilingForm 6-K - Stock Titan

Apr 20, 2026
pulisher
Apr 20, 2026

Novo Nordisk A/S stock (DK0062498333): Is obesity drug dominance strong enough to unlock new upside? - AD HOC NEWS

Apr 20, 2026
pulisher
Apr 19, 2026

Novo Nordisk A/S stock (DK0062498333): Is obesity drug dominance strong enough to sustain growth? - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 19, 2026

Novo Nordisk A/S stock (DK0062498333): Is its obesity drug dominance strong enough to unlock new ups - AD HOC NEWS

Apr 19, 2026
pulisher
Apr 18, 2026

Novo Nordisk Extends Lead As Eli Lilly New Obesity Pill Sees Modest Launch Uptake - Sahm

Apr 18, 2026
pulisher
Apr 18, 2026

NVO Stock Quote Price and Forecast - CNN

Apr 18, 2026
pulisher
Apr 17, 2026

NVO Forecast, Price Target & Analyst Ratings | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill

Apr 17, 2026
pulisher
Apr 15, 2026

UBS (NYSE: UBS) offers autocallable notes tied to Novo Nordisk ADRs due 2027 - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

UBS (AMUB) offers autocallable contingent-yield notes linked to Novo Nordisk ADRs - Stock Titan

Apr 15, 2026
pulisher
Apr 15, 2026

Novo Nordisk A/S Sponsored ADR Class B Trade Ideas — BMV:NVO/N - TradingView

Apr 15, 2026
pulisher
Apr 13, 2026

Novo Nordisk EVOKE Update Raises Questions On Growth Beyond Obesity And Diabetes - Sahm

Apr 13, 2026
pulisher
Apr 11, 2026

Novo Nordisk Leans Into Obesity Care With ORION Data And Wegovy Pricing - Sahm

Apr 11, 2026
pulisher
Apr 10, 2026

NVO News | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill

Apr 10, 2026
pulisher
Apr 09, 2026

Novo Nordisk Wins EU Nod To Ease Wegovy Injection Delivery - Sahm

Apr 09, 2026
pulisher
Apr 08, 2026

Novo Nordisk A/ S stock: Why it's still a powerhouse amid volatility - AD HOC NEWS

Apr 08, 2026
pulisher
Apr 07, 2026

Novo Nordisk (NYSE: NVO) details progress in DKK 15B buyback - Stock Titan

Apr 07, 2026
pulisher
Apr 06, 2026

Novo Nordisk A/ S stock: Weight-loss boom far from over — what investors need to know - AD HOC NEWS

Apr 06, 2026
pulisher
Apr 04, 2026

Novo Nordisk A/S (NVO) Stock Price, News, Quote & History - Yahoo! Finance Canada

Apr 04, 2026
pulisher
Apr 04, 2026

Novo Nordisk Wegovy Subscription Targets Self Pay Demand And Investor Focus - Sahm

Apr 04, 2026
pulisher
Apr 02, 2026

NVO Stock Chart | NOVO-NORDISK A/S-SPONS ADR (NYSE:NVO) - ChartMill

Apr 02, 2026
pulisher
Apr 01, 2026

Novo Nordisk A/S Stock: Navigating GLP-1 Leadership Amid Evolving Obesity Treatment Landscape - AD HOC NEWS

Apr 01, 2026
pulisher
Mar 31, 2026

Slash Your Wegovy Costs: Novo Nordisk Reveals First-Ever Subscription Plan - Sahm

Mar 31, 2026
pulisher
Mar 30, 2026

Novo Nordisk (NYSE: NVO) details progress on DKK 15bn share repurchase - Stock Titan

Mar 30, 2026
pulisher
Mar 30, 2026

Novo Nordisk A/S Stock: Pipeline Innovations Amid Share Price Pressures and Market Challenges - AD HOC NEWS

Mar 30, 2026
pulisher
Mar 29, 2026

Novo Nordisk Voucher Win Meets Rising Scrutiny Of FDA Review Program - Sahm

Mar 29, 2026
$344.55
price down icon 1.17%
$130.40
price down icon 2.42%
PFE PFE
$27.00
price up icon 1.24%
MRK MRK
$111.90
price down icon 2.37%
NVS NVS
$145.47
price down icon 1.36%
Capitalizzazione:     |  Volume (24 ore):